CEL Celadon Pharmaceuticals Plc

    RNS Number : 1914F
  Celsis International PLC
  06 October 2008
   


 For filings with the FSA include the annex
 For filings with issuer exclude the annex 

 TR-1: Notifications of Major Interests in Shares

 1. Identity of the issuer or the underlying                Celsis
 issuer of existing shares to which voting       International Plc
 rights are attached:


 2. Reason for notification (yes/no)
                                                                             Yes
 An acquisition or disposal of voting rights
                                                                              No
 An acquisition or disposal of financial instruments which may result
 in the acquisition of shares already issued to which voting rights
 are attached 
                                                                              No
 An event changing the breakdown of voting rights

 Other (please specify):______________

 3. Full name of person(s) subject to notification   Loeb Partners Corporation
 obligation:
                                                                    (as above)
 4. Full name of shareholder(s) (if different from
 3):
                                                               02 October 2008
 5. Date of transaction (and date on which the
 threshold is crossed or reached if different):
                                                               06 October 2008
 6. Date on which issuer notified:
                                                                        4%, 3%
 7. Threshold(s) that is/are crossed or reached:


 8: Notified Details
 A: Voting rights attached to shares

 Class/type of shares  Situation previous to the triggering        Resulting situation after the triggering transaction
 If possible use ISIN  transaction
 code
                       Number of shares      Number of voting      Number of shares  Number of voting        Percentage of voting
                                             rights                                  rights                  rights

                                                                                     Direct   Indirect       Direct        Indirect
                                    778,905               778,905           478,905  478,905              -         2.19%
 GB00BOCD5F69



 B: Financial Instruments

 Resulting situation after the triggering transaction

 Type of financial instrument  Expiration date  Exercise/ conversion  No. of voting rights  Percentage of voting
                                                period/date           that may be acquired  rights
                                                                      (if the instrument
                                                                      exercised/converted)
 N/A



 Total (A+B)

 Number of voting rights  Percentage of voting rights
 478,905                                        2.19%



 9. Chain of controlled undertakings through which the voting rights and /or
 the financial instruments are effectively held, if applicable:
 N/A

 Proxy Voting:

 10. Name of proxy holder:                                         N/A

 11. Number of voting rights proxy holder will cease to hold:

 12. Date on which proxy holder will cease to hold voting rights:


 13. Additional information:     Shelby Drescher

 14 Contact name:               + 1 212 483 7070

 15. Contact telephone number:


    For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLUNVSRWKRRRAA

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024